Spire Healthcare Group PLC · LSE:SPI

Spire Healthcare — Investor Presentation (February 2011)

52 slides from Spire Healthcare's investor presentation, Feb 12, 2011

  1. Slide 1: Kesava Reddy Mannur, Consultant in Bariatric Surgery

    Kesava Reddy MANNUR Director / Consultant in Bariatric Surgery Homerton University Hospital SPIRE Roding Hospital Private: 020 8989 8702 Spire: Mary Casey www.londonobesitycentre.com

  2. Slide 2: Body Mass Index BMI

    Body Mass Index BMI BMI = Wt in kg/Ht in m2 Waist circumference 102 cm (40in) – Men 88 cm (35in) - women Measurement of body fat

  3. Slide 3: Body Mass Index (BMI) = kg/m2

    NORMAL OVERWEIGHT OBESE SEVERELY OBESE MORBIDLY OBESE BMI 18.5 – 24.9 BMI 25 – 29.9 BMI 30 – 34.9 BMI 35 – 39.9 BMI ≥ 40 Body Mass Index (BMI) = kg/m2

  4. Slide 4: Health Profile of England

    Health Profile of England 2007 Overweight or obese 23% males 24% females Morbid obesity 0.6% men 1.9% women

  5. Slide 5: Obese patients and surgery numbers

    1,200,000 obese paients 5% rise per year 2% of these pts – 27,783 need surgery 4341 surgeries in 2005 2000 surgeries in 2008 (NHS) - national audit office

  6. Slide 6: BMI > 30 risks

    BMI > 30 – 55% increase in mortality – 70% increase in coronary artery disease – 75% increase in stroke – 400% increase in diabetes Morbidly obese males between 25 and 35 : 12x the chance of mortality as normal weight men A morbidly obese adult : 33% chance of living to age 65 as that of a normal we

  7. Slide 7: Relative Mortality Rate

    Exponential Increase in Risk 400 350 Relative Mortality Rate High risk 300 Medium risk 250 Low risk 200 150 100 50 0 16 19 22 25 28 31 34 37 40 45 BMI (kg/m2) NIH, NEJM, 1995.

  8. Slide 8: BMI classification and disease risk

    This table shows the way different BMls are classified and the relationship between BMI and risk of associated diseases Body Mass Index Classification Risk of disease associated (kg/m2) with excess weight Less than 20 Underweight Low (but increased risk of other clinical problems) Over 20 to 25 Desi

  9. Slide 9: Increased risk of associated diseases for the obese

    Estimated increased risk for the obese of developing associated diseases, taken from international studies Disease Relative risk - women Relative risk - men Type 2 Diabetes * 12.7 5.2 Hypertension 4.2 2.6 Myocardial Infarction 3.2 1.5 Cancer of the Colon 2.7 3.0 Angina 1.8 1.8 Gall Bladder Diseases

  10. Slide 10: Obesity-related comorbidities

    Diabetes GORD Hypertension Arthritis – weight bearing Sleep Apnoea Low back pain Lipid disorders Infertility & Menstrual Ischaemic heart disease problems/ PCOS Cardiomyopathy Obstetric Complications Pulmonary hypertension DVT & thromboembolism Asthma Depression Hypoventilation syndromes Immobility G

  11. Slide 11: Cost per patient per year

    Cost per patient per year Obesity Cost/patient/yr Related Year Source £ Disease CODE 2 Study, Type 2 diabetes 1999 1550 UK Coronary Heart Lui JLY, Heart 1999 1182 Disease 2002 Colorectal O’Leary BA, 7936 Cancer 2004

  12. Slide 12: Metabolic syndrome criteria

    1. Waist circumference – >88 cm for women >102 cm for men 2. Serum Triglycerides >1.69mmo/L 3. HDL Cholesterol <1.29 mmol/L for women <1.04 mmol/L for men 4. Blood Pressure 130/85 or treated hypertension 5. Fasting Blood glucose >6.1mmol/L - (ATP III criteria)

  13. Slide 13: Surgery outcomes on comorbidities

    Diabetes - 76.8% = 98.9%(BPD/DS), 83.7%(gastric bypass), 47.5%(gastric banding) Hypertension – 61.7% =83.4%(BPD/DS), 67.5%(gastric bypass), 43.2%(gastric band) Obstructive Sleep apnoea – 83.6% =91.9%(BPD/DS), 80.4%(gastric bypass) Hyperlipidaemia – 70% =99.1% (BPD/DS), 96.5%(gastric bypass) ▪ Buchwa

  14. Slide 14: Swedish study: surgery vs obese controls

    Compared the obesity people with surgically treated people over 10 years 2037 obesity people to 2010 surgically treated Wt change significant: 1.6% gain to 16.1% loss Unadjusted overall mortality reduced by 31.6% in the surgery group Death from MI (25 control, 13 surgery), cancer ( 47 control, 29 su

  15. Slide 15: Bypass mortality study

    1984 – 2002 Bypass 9949 pts Obese control- 7925 Matched for age, sex and BMI 7.1 yr follow up 40% decrease in mortality in surgical group (37.6 vs 57.1 deaths per 10,000 person years) ▪ Ted D.Adamset al. NEJM Aug 23, 2007, Vol 357, Iss 8,pg.753

  16. Slide 16: Slide 16

  17. Slide 17: Economic impact of surgery

    If 5% of patients received surgery * EXCLUDING AFTERCARE COSTS. SOURCE: OFFICE OF HEALTH ECONOMICS Component Year 1 £m Year 2 £m Year 3 £m Total year 1 to year 3 £m Paid hours gained 135 135 135 405 NHS cost/savings -8 56 56 104 Total savings 127 191 191 104 Cost of surgery* -127 191 191 509 Total e

  18. Slide 18: Shedding the Pounds

    Shedding the Pounds •If just five per cent of NICE-eligible patients were to receive bariatric surgery, the total net gain to the economy within three years would be £382m. •If 25 per cent of NICE-eligible patients were to receive bariatric surgery, the total net gain to the economy within three yea

  19. Slide 19: PCT use of NICE guidance

    •Half of PCTs use only ‘elements’ of the guidelines set out by NICE guidance to determine who qualifies for bariatric surgery. •One in ten PCTs ignore the guidance completely. •Three quarters of PCTs do not track the outcomes for patients of bariatric operations. •One third of PCTs said they would b

  20. Slide 20: Assessment steps for obese patients

    1. Measure Ht, wt, BP. 2. Assess comorbidities – diabetes, sleep apnoea/resp problems 3. Measure waist circumference 4. Check FBC, LFT, Glucose, TFT, vit D, B12 5. Is the pt ready and motivated 6. Which diet you should recommend; Discuss a physical activity 7. Give the pt copies of diet and activity

  21. Slide 21: NICE criteria for surgery

    BMI >40KG/M² BMI >35 KG/M² with comorbid factors diabetes, respiratory problems – sleep apnoea, hypertension, joint problems TRIED NON-SURGICAL METHODS-no sustained weight loss for 6 months Understands the surgery Willing to be followed up for life Be fit to undergo surgery Doesn’t have serious ment

  22. Slide 22: Special cases: BMI over 50, adolescents

    1. Pts with BMI > 50kg/m2 Surgery direct. Medication while waiting for surgery to reduce weight 2. Surgery for adolescents Could be performed in selected cases 3. Nonsurgical weight reduction measures in any setting (not just hospital setting) like GP surgeries, weight loss units

  23. Slide 23: Weight loss by procedure

    Gastric Banding(Belachew 1998) 55%6yr Gastric bypass (Dietel 98) 68%5yr Biliopancreatic div(Scopinoro 96) 77%8yr Biliopanc+duod switch(Hess98) 70%8yr

  24. Slide 24: Slide 24

  25. Slide 25: Gastric banding complications

    REFLUX OESOPHAGITIS - variable POUCH DILATATION/BAND SLIPPAGE – 3-5% BAND EROSION – 3-5% PORT INFECTION – 2% BAND LEAKAGE – 1% PORT RELATED PROBLEMS – 15% Personal: 600

  26. Slide 26: Gastric Bypass

    Gastric Bypass Small gastric pouch Roux-en-Y biliary limb = 50- 75cm alimentary (Roux) limb =100 – 150cm

  27. Slide 27: Gastric bypass complications

    Anastamotic leak = 0.5% (none in the last 950) Anastamotic stricture/ulcer =2-5% Nutritional deficencies – Vit B12,Vit D, Fe, ca Dumping Syndrome – variable (light-headedness,sweating,abdominal colic, diarrhoea) Weight regain (10kg) in the long term follow up (55%)

  28. Slide 28: Advantages and disadvantages

    Advantages No re-routing of bowel - No malabsorption No foreign body Low maintenance Start losing weight straight away Disadvantages: The stomach expands with time – may start putting on weight Long staple line – more chance of staple disruption: 1:150

  29. Slide 29: Duodenal switch

    ) - Duodenal switch Bariatric Surgery for Super Obese (BM VERTICAL GASTRECTOMY WITH DUODENAL SWITCH

  30. Slide 30: Sleeve gastrectomy and duodenal switch

    1st: Sleeve (vertical) gastrectomy – removes ¾ stomach – left with 60-100cc 2nd: Duodenal switch Pylorous & 2-4 cm Duodenum preserved. No blind stomach Distal bypass – bypassing to 100 cm from the ileocaecal junction.

  31. Slide 31: Duodenal switch risks

    Difficult surgery Takes more time Risk of death 1:100 Smelly stools Metabolic problems – osteoporosis/osteomalacia, vitamin deficiencies, protein malnutrition

  32. Slide 32: Univariate analysis of 2000 patients

    Univariate analysis on 2000 pts: surgeon’s experience age(<50) BMI (<60) comorbidities(<5) intraoperative steriod boluses - McCarty, Arnold. Lamont, Kahn Ann Surg Oct 2005

  33. Slide 33: What surgeries when?

    What surgeries when?

  34. Slide 34: Patient selection: BMI under 45

    BMI <45 Not carbohydrate /sweet eater Not a snacker Not a binge eater Not a Sweet eater No appropriate medical facility Most important: unsure of the patient’s Compliance ? GORD ??Diabetes

  35. Slide 35: Patient selection: BMI over 45

    BMI > 45 Diabetic GORD/Heartburn Doubtful about the diet compliance Sweet eaters/ grazers/’pickers’

  36. Slide 36: Sleeve gastrectomy indications

    Stand alone with BMI <45 -To have immediate effect - no foreign body As a preliminary to Duodenal Switch (2nd Stage) in patients with Less BMI but with comorbid factors or High BMI > 55

  37. Slide 37: BMI over 55

    >55 BMI Extreme carbohydrate Eaters Binge Eaters Snackers MAINLY DONE IN 2 STAGES: 12-18Mts apart

  38. Slide 38: Hospital stay and recovery

    Hospital stay for 2 nights. (Band 1 night) Should be able to drive by 5th day Should be able to go to gym and swim by 2 weeks Extreme physical work by 3-4 weeks Should be on liquids for4 weeks = First 2 weeks = liquids without bits Next 2 weeks = blenderised/liquidised food Most important – sip, not

  39. Slide 39: Follow-up schedule

    3 monthly in the first year Except in gastric band where the band has to be tightened at 2 weekly intervals six weeks after surgery 6 monthly after the first year Check FBC,U&E,LFT,Ca,VitD &B12&Folate Regular multivitamin tablets. May need Calcichew with D3. May need B12 injection Think of giving B1

  40. Slide 40: Slide 40

  41. Slide 41: Tight band or slippage

    - May have tight band. wey have band slippage/gastric pouch r gastric erosion. ‘May be force eating =|Immediate deflation of band qastrograffin/barium swallow .

  42. Slide 42: Patient had a lap gastric band

    Patient had a lap gastric band.

  43. Slide 43: Management options

    4. Start on Antibiotics for gm Eo Sta phylococcal i l infection. 2. Send the patient to a ho spital where they deal with obesity surgery.

  44. Slide 44: Patient with gastric bypass

    Another patient with gastric bypass a few months ago.

  45. Slide 45: Internal hernia

    al Hernia hink of Intern on/urgent ent to 5 Surgeon woes ¢€ on

  46. Slide 46: Another patient with gastric bypass

    You have You now another patient have now another patient with with gastric bypass. gastric bypass

  47. Slide 47: Dumping syndrome

    Dumping Syn

  48. Slide 48: Metabolic surgery for diabetes patients

    Metabolic surgery – for Diabetes Patients with BMI of 22 – 35 kg/m2 good resolution of the diabetes ▪ 1. GASTRIC BYPASS ▪ 2. ILEAL INTERPOSITION ▪ 3. DUODENO-JEJUNAL INTERPOSITION NOTES – endoscopic gastric bypass and sleeve gastrectomy

  49. Slide 49: Conclusion

    Laparoscopic obesity surgery in a multidisciplinary team setting offers an excellent method of reducing the weight - with little morbidity and extremely low mortality in appropriately selected patients in experienced hands Offer the appropriate treatment to get best results This in turn offers enorm

  50. Slide 50: Useful websites

    www.nice.org.uk www.bospa.org.uk www.wlsinfo.org.uk www.duodenalswitch.com www.londonobesitycentre.com www.aso.org.uk

  51. Slide 51: ~_

    ~_

  52. Slide 52: Ll

    Ll

Spire Healthcare Group — Investor Presentation (February 2011) on 6ix